PMcardio receives FDA Breakthrough Device Designation — read the full story
Powerful Medical
13. March 2023

Powerful Medical in the Heart magazine, the official journal of the British Cardiovascular Society

Heart Magazine is a global, peer-reviewed journal that keeps cardiologists informed of the latest breakthroughs in cardiovascular disease and provides an opportunity for researchers and readers to connect and advance medical science and patient care.

Powerful Medical has recently appeared in the latest issue, discussing the transformative effects of devices such as PMcardio on how healthcare professionals in primary and emergency care manage cardiac patients.

From interpreting ECGs to referring patients to further care, our recently launched AI-powered medical device, PMcardio, is already making a mark on healthcare in the UK.

The issue is now in circulation around the UK, but you can also read the article below.

Optimising Patient Care Through AI-Powered Medical Decision-Making: PMcardio Launches in the UK

Artificial intelligence (AI) has been making waves in almost every industry, and the healthcare sector is no exception. AI has the potential to revolutionise the way medical professionals diagnose, treat, and prevent diseases. This includes the field of cardiology, where AI has already made a significant impact, providing a new level of accuracy and efficiency to the field.

The UK healthcare system is poised to receive a major boost with the launch of PMcardio, a cutting-edge AI-powered MDR-certified Class IIb medical device. PMcardio is a smartphone application that provides healthcare professionals with the ability to diagnose and treat cardiovascular diseases with unmatched speed and accuracy.

PMcardio is a game changer in primary care, as it empowers general practitioners to improve their gatekeeping function for patient access to specialised care, such as cardiology. With this tool having the cardiologist at the fingertips, it ensures timely and accurate referrals, resulting in optimised patient outcomes.

Although intended mainly for primary, emergency and hospital care, the revolutionary ECG interpretation service plays a major role in unburdening cardiologists by reducing incorrect referrals and enabling them to treat patients that actually require specialist care. Integration of the medical device further helps identify high-risk patients, resulting in early and adequate treatment of patients suffering from critical conditions such as acute coronary syndrome.

“I see the role of AI in assuring the best understanding of heart disease and enabling tailored treatment of individual patients. PMcardio can really contribute to saving lives and improving outcomes”, states Prof. Dr. Jozef Bartunek, PhD, Associate Director and Chairman of the Cardiovascular Center in Aalst and visiting professor at the University Leuven.

With its ability to analyse large datasets quickly and accurately predict outcomes based on past patients, there’s no doubt that AI will become an invaluable tool for improving patient care.

“Physicians who are open to new technologies like PMcardio and ready to unleash their potential will be in a huge advantage compared to those who will remain reluctant to artificial intelligence,” says Prof. Dr. Robert Hatala, PhD, Head of the Arrhythmology Department at the Slovak National Institute of Cardiovascular Diseases.

PMcardio represents a major leap forward in the use of AI technology in healthcare, providing healthcare professionals with unparalleled precision in diagnosing 38 cardiovascular diseases. The app enables accurate patient triage and provides treatment recommendations that adhere to up-to-date guidelines, ensuring the highest standard of care.

“With its training on a database of over a million ECG records, PMcardio surpasses the diagnostic accuracy of general practitioners and matches the expertise of seasoned cardiologists”, explains Dr. Robert Herman, Chief Medical Officer at Powerful Medical. By utilising AI image recognition to scan and reconstruct ECG strips into digital waveforms, PMcardio’s machine learning technology recognises patterns and anomalies to provide highly accurate diagnoses. AI-augmented interpretation of ECGs allows physicians to process more ECGs with the accuracy of a cardiologist and provides a valuable second opinion in diagnostic and treatment decisions.

To conclude, it is essential to emphasise that AI technologies such as PMcardio are not intended to replace medical professionals. Despite the advancements in technology, physicians remain the primary decision-makers in patient care and treatment.

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

Share this article

Don't miss these

Image is showing logos of the two companies mentioned in the text - PMcardio and Alphaiota

Alphaiota Expands Strategic Partnership with PMcardio to Launch First AI-Powered Heart Attack Diagnostic Platform in Saudi Arabia

Alphaiota and PMcardio announce the expansion of their strategic partnership to bring the first AI-powered heart attack diagnostic solution to the Kingdom of Saudi Arabia. Developed by Powerful Medical, a medical device manufacturer specializing in AI-driven cardiovascular diagnostics, PMcardio will be introduced by Alphaiota as the exclusive distributor in the region, marking a first-of-its-kind deployment in the Middle East.
Image ilustrating the VAIA grant reception containing logos of important public institutions

Powerful Medical Awarded €1M EU-Funded Grant by Slovak Ministry of Economy to Advance AI-ECG Heart Attack Diagnostics

Powerful Medical has received over €985,000 in funding from the Slovak Ministry of Economy, as part of the EU-funded Recovery and Resilience Plan. The grant supports the continued development of our AI-based ECG interpretation technology, focused on improving early diagnosis and treatment of acute coronary syndromes (ACS).

Join over 100,000 healthcare professionals who are already taking advantage of AI